Specialized Technologies
Unparalleled experience in the development of unique oral dose delivery systems.
We’re experts in taste masking & controlled release for oral and injectable dosage forms
- Leading partner to pharmaceutical companies across Branded, Specialty, Generic, and OTC segments
- Portfolio of >65 commercial products globally across multiple therapeutic areas
- Expertise from product development to GMP approved commercial manufacturing
- 3 R&D and manufacturing locations
- > 500 employees
Sources:
- VitalStim Therapy (2005). Dysphagia: Fact sheet. Â
- Mennella, J. A., Spector, A. C., Reed, D. R., & Coldwell, S. E. (2013). The bad taste of medicines: overview of basic research on bitter taste. Clinical therapeutics, 35(8), 1225-1246.
- DeRoche, C., Macclaren, G., & Sonies, B. (2000). Pill Swallowing in America: A National Survey of Adults. Harris Interactive Survey.
- St. John’s University.
We’re experts in taste masking & controlled release for oral and injectable dosage forms
Dysphagia
- 1 in 17 people will develop dysphagia in their lifetime
- Indication specific dysphagia can result from a variety of diseases including stroke, MS, mental health disorders, GERD, and cancers of the throat
Pediatrics
- Unpleasant taste is the biggest barrier for completing treatment in pediatrics
- Proper taste masking increases compliance 53% to 90%
Geriatrics
- 26% of geriatric patients reported difficulty swallowing tablets and capsules
- Extended release formulations and titratable dosage forms are required to improve compliance
For more information on the specialized delivery technologies provided by Adare, review the Related Resources and speak with one of our experts today.
RELATED RESOURCES
SPECIALIZED TECHNOLOGIES
LATEST NEWS
EVENTS
Speak With An Expert
XXXX
Senior Director, Pharmaceutical Sciences, Business Support, and New Technologies
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.